Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial
- PMID: 28497478
- DOI: 10.1111/and.12829
Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial
Abstract
The aim of the study was to compare the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation (PE). In a single-blind placebo-controlled clinical study, 150 PE patients without erectile dysfunction (ED) were included during the period of March 2015 to May 2016. Patients were randomly divided into five groups (30 patients each). On demand placebo, paroxetine (30 mg), dapoxetine (30 mg), sildenafil citrate (50 mg) and combined dapoxetine (30 mg) with sildenafil citrate (50 mg) were given for patients for 6 weeks in each group respectively. All patients were instructed to record intravaginal ejaculatory latency time (IELT) and evaluated with Premature Ejaculation Diagnostic Tool (PEDT) and the patient satisfaction score before and after treatment. The mean of IELT, satisfaction score and PEDT in all groups was significantly improved after treatment (p value = .001). Combined dapoxetine with sildenafil group had the best values of IELT, satisfaction scores and PEDT in comparison with other treatment groups (p value <.001). The combined dapoxetine with sildenafil therapy could significantly improve PE patients without ED as compared to paroxetine alone or dapoxetine alone or sildenafil alone with tolerated adverse effects.
Keywords: dapoxetine; paroxetine; premature ejaculation; sildenafil.
© 2017 Blackwell Verlag GmbH.
Similar articles
-
Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study.Int J Impot Res. 2019 Mar;31(2):92-96. doi: 10.1038/s41443-019-0122-2. Epub 2019 Jan 31. Int J Impot Res. 2019. PMID: 30705437 Clinical Trial.
-
Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.J Sex Med. 2013 Sep;10(9):2312-25. doi: 10.1111/jsm.12236. Epub 2013 Jul 11. J Sex Med. 2013. PMID: 23845016 Clinical Trial.
-
Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.Clin Neuropharmacol. 2006 Sep-Oct;29(5):243-52. doi: 10.1097/01.WNF.0000228210.12194.46. Clin Neuropharmacol. 2006. PMID: 16960468 Clinical Trial.
-
Dapoxetine: in premature ejaculation.Drugs. 2010 Jul 30;70(11):1433-43. doi: 10.2165/11204750-000000000-00000. Drugs. 2010. PMID: 20614950 Review.
-
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.Drug Saf. 2012 May 1;35(5):359-72. doi: 10.2165/11598150-000000000-00000. Drug Saf. 2012. PMID: 22452563 Review.
Cited by
-
Prospective comparison of tadalafil 5 mg, dapoxetine 30 mg, and the combination of both in the treatment of premature ejaculation.Arab J Urol. 2023 Nov 6;22(2):81-88. doi: 10.1080/20905998.2023.2277081. eCollection 2024. Arab J Urol. 2023. PMID: 38481411 Free PMC article.
-
HPLC-UV and UPLC-MS/MS methods for the simultaneous analysis of sildenafil, vardenafil, and tadalafil and their counterfeits dapoxetine, paroxetine, citalopram, tramadol, and yohimbine in aphrodisiac products.RSC Adv. 2021 Feb 18;11(14):8055-8064. doi: 10.1039/d0ra10324a. eCollection 2021 Feb 17. RSC Adv. 2021. PMID: 35423308 Free PMC article.
-
An update on the treatment of premature ejaculation: A systematic review.Arab J Urol. 2021 Aug 4;19(3):281-302. doi: 10.1080/2090598X.2021.1943273. eCollection 2021. Arab J Urol. 2021. PMID: 34552780 Free PMC article. Review.
-
Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs).Curr Neuropharmacol. 2022;20(4):693-712. doi: 10.2174/1570159X19666210517150418. Curr Neuropharmacol. 2022. PMID: 33998993 Free PMC article. Review.
-
Selective serotonin re-uptake inhibitors for premature ejaculation in adult men.Cochrane Database Syst Rev. 2021 Mar 21;3(3):CD012799. doi: 10.1002/14651858.CD012799.pub2. Cochrane Database Syst Rev. 2021. PMID: 33745183 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources